Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

26,246 signal articles · 262 in last 24h · 126,026 total before filter · latest 13m ago
262last 24h
1201last 7d
175● bullish (7d)
130● bearish (7d)
205publishers
AllMacro228Earnings424M&A93Regulatory22Product11Analyst11
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Morning Bid: Buy the chip
Reuters78d agobullish
Morning Bid: Buy the chip

By Mike Dolan June 9 (Reuters) - What matters in U.S. and global markets today By Mike Dolan, Editor-at-Large, Finance and Markets Relief rally, dip-buying or a dead cat bounce?

ASML Becomes Europe’s Most Valuable Stock As Valuation And Growth Expectations Soar
Simply Wall St.78d agobullish
ASML Becomes Europe’s Most Valuable Stock As Valuation And Growth Expectations Soar

ASML Holding (NasdaqGS:ASML) has become the most valuable European stock ever, setting a new all time high in market capitalization. The move is tied to demand for advanced chip manufacturing equipment and ASML’s position as the only supplier of key EUV lithography systems. The company has raised its full year revenue outlook and highlighted a strong backlog, pointing to solid order visibility from chipmakers. For investors watching ASML Holding (NasdaqGS:ASML), the new valuation milestone...

Chip Stocks Rebound Amid Dip Buying
Barrons.com78d agobullish
Chip Stocks Rebound Amid Dip Buying

Chip-related stocks rebounded in Asia after a market rout in the previous session. Samsung Electronics and SK Hynix, which account for about half of the South Korea's Kospi market capitalization, jumped 9.

Bloomberg78d agobullish
GSK Buys Nuvalent for $10.6 Billion in Major Cancer Push

(Bloomberg) -- GSK Plc agreed to buy Nuvalent Inc. for $10.6 billion, securing a US biotech firm developing treatments for lung cancer as part of the British pharmaceutical company’s effort to rebuild its oncology franchise.Most Read from BloombergHouse Republican Says Hegseth’s D-Day Remarks ‘Inappropriate’LA Mayor Race Flips as Socialist Beats Reality TV Star PrattTrump’s $100,000 H-1B Visa Application Fee Rejected by JudgeTrump Says He, Not Congress, Is in Charge of Kennedy Center in Reversal

Stock Futures Rise as Markets Pile Into the Tech Dip
Barrons.com78d agobullish
Stock Futures Rise as Markets Pile Into the Tech Dip

Stocks looked set to rise on Tuesday as investors continued to buy the dip, taking advantage of last week’s artificial intelligence selloff to snap up shares in tech companies on the cheap. The Nasdaq and the S&P both rallied on Monday as the market piled back into chip makers and other momentum stocks. The dip-buying may well have legs, although it’s possible that either consumer-price inflation data or quarterly earnings from Oracle on Wednesday could snap the rebound.

Jefferies Upgrades RTX Corporation (RTX) To Buy From Hold
Insider Monkey78d agobullish
Jefferies Upgrades RTX Corporation (RTX) To Buy From Hold

RTX Corporation (NYSE:RTX) is among the 10 Best Aerospace and Defense Stocks to Buy According to Hedge Funds. On June 4, Jefferies analyst Sheila Kahyaoglu upgraded the stock to Buy from Hold and set a new price target of $220, up from $210. According to Barron’s, the analyst cited rising profit margins, growth prospects in […]

Why Are Micron (MU) Shares Soaring Today
StockStory78d agobullish
Why Are Micron (MU) Shares Soaring Today

Shares of memory chips maker Micron (NASDAQ:MU) jumped 7.9% in the afternoon session after investor optimism in the AI memory sector improved, sparked by Nvidia's announcement of a multi-year technology partnership with peer SK Hynix.

Goldman Sachs Trims Amgen (AMGN) Valuation but Sticks with Buy Rating
Insider Monkey78d agobullish
Goldman Sachs Trims Amgen (AMGN) Valuation but Sticks with Buy Rating

With a net profit margin of 20.96%, Amgen Inc. (NASDAQ:AMGN) is included among the 10 Most Profitable Dividend Stocks to Invest In Now. On June 5, Goldman Sachs lowered its price recommendation on Amgen Inc. (NASDAQ:AMGN) to $389 from $425. It reiterated a Buy rating on the stock. The firm adjusted its model after Amgen disclosed […]